Resonetics closes $900M nitinol deal and rebrands Memry and Smart Materials

Nitinol is used for a variety of medtech applications. [Photo via Adobe Stock]

Resonetics has closed on its $900 million acquisition of the SAES Getters medical nitinol business.

Nashua, New Hampshire-based Resonetics said it will rebrand Memry Corporation and SAES Smart Materials as Resonetics.

The Smart Materials business creates raw nitinol alloy from nickel and titanium and produces nitinol wires, bars, ribbons and sheets. The Memry business offers electric discharge machining, laser processing, centerless grinding, and nitinol tubing, sheet, and wire fabrication. 

Those two companies have around 600 employees at facilities in Bethel, Connecticut, New Hartford, New York, and Menlo Park, California.

Nitinol has superelastic and shape memory properties that make it uniquely useful for a variety of medical applications. Medical device developers are finding new and improved ways to use nit…

Read more
  • October 2, 2023
  • 0

Resonetics to buy SAES Medical nitinol business for $900M

Resonetics announced today that it has signed an agreement to acquire Memry Corp. and SAES Smart Materials from SAES Getters S.p.A, Milan, Italy.

The planned acquisition will expand Nashua, New Hampshire–based Resonetics’ nitinol raw material and component manufacturing capabilities.

The companies expect the $900 million deal to close this year. The transaction is subject to the receipt of regulatory clearances and approvals. In addition, there are other closing conditions, including the approval of the SAES Getters S.p.A. board of directors.

Both of the businesses that Resonetics is acquiring are U.S. based. They have 550 employees and operations in Bethel, Connecticut; New Hartford, New York; and Menlo Park, California.

The deal enables Resonetics to better serve a wide range of medtech

Nitinol is enabling technological advances in a range of therapeutic areas, such as structural heart, peripheral vascular, electrophysiology, neurovascular…

Read more
  • January 9, 2023
  • 0